164 related articles for article (PubMed ID: 29507109)
1. Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis.
Singh T; Fakiola M; Oommen J; Singh AP; Singh AK; Smith N; Chakravarty J; Sundar S; Blackwell JM
J Immunol; 2018 Apr; 200(8):2727-2737. PubMed ID: 29507109
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR Class II expression on myeloid and lymphoid cells in relation to HLA-DRB1 as a genetic risk factor for visceral leishmaniasis.
Singh B; Fakiola M; Sudarshan M; Oommen J; Singh SS; Sundar S; Blackwell JM
Immunology; 2019 Feb; 156(2):174-186. PubMed ID: 30403401
[TBL] [Abstract][Full Text] [Related]
3. Human genetics of leishmania infections.
Blackwell JM; Fakiola M; Castellucci LC
Hum Genet; 2020 Jun; 139(6-7):813-819. PubMed ID: 32055998
[TBL] [Abstract][Full Text] [Related]
4. Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects.
Vijayamahantesh ; Amit A; Dikhit MR; Singh AK; Venkateshwaran T; Das VNR; Das P; Bimal S
Microbes Infect; 2017 Jun; 19(6):358-369. PubMed ID: 28373107
[TBL] [Abstract][Full Text] [Related]
5. Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides.
Mamedov A; Vorobyeva N; Filimonova I; Zakharova M; Kiselev I; Bashinskaya V; Baulina N; Boyko A; Favorov A; Kulakova O; Ziganshin R; Smirnov I; Poroshina A; Shilovskiy I; Khaitov M; Sykulev Y; Favorova O; Vlassov V; Gabibov A; Belogurov A
Front Immunol; 2019; 10():3088. PubMed ID: 32010139
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population.
Baleotti W; Ruiz MO; Fabron A; Castilho L; Giuliatti S; Donadi EA
Transfusion; 2014 Oct; 54(10):2468-76. PubMed ID: 24724911
[TBL] [Abstract][Full Text] [Related]
7. DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9.
Chow IT; James EA; Tan V; Moustakas AK; Papadopoulos GK; Kwok WW
Mol Immunol; 2012 Feb; 50(1-2):26-34. PubMed ID: 22196942
[TBL] [Abstract][Full Text] [Related]
8. Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs).
Delgado G; Parra-López CA; Vargas LE; Hoya R; Estupiñán M; Guzmán F; Torres A; Alonso C; Velez ID; Spinel C; Patarroyo ME
Parasite Immunol; 2003 Apr; 25(4):199-209. PubMed ID: 12940963
[TBL] [Abstract][Full Text] [Related]
9. Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC).
Dikhit MR; Amit A; Singh AK; Kumar A; Mansuri R; Sinha S; Topno RK; Mishra R; Das VNR; Pandey K; Sahoo GC; Ali V; Bimal S; Das P
Parasite Immunol; 2017 Sep; 39(9):. PubMed ID: 28665520
[TBL] [Abstract][Full Text] [Related]
10. HLA-DRB1 molecules and the presentation of anchor peptides from RhD, RhCE, and KEL proteins.
De Souza CP; Baleotti W; Moritz E; Sanches S; Lopes LB; Chiba AK; Donadi EA; Bordin JO
Transfusion; 2021 May; 61(5):1617-1630. PubMed ID: 33675036
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the immunomodulatory responses of LdODC-derived MHC Class-II restricted peptides against VL.
Pandey R; Dikhit MR; Kumar A; Dehury B; Pandey K; Topno RK; Das P; Bimal S
Parasite Immunol; 2020 Apr; 42(4):e12699. PubMed ID: 31976563
[TBL] [Abstract][Full Text] [Related]
12. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1 Alleles Associated with Lower Leishmaniasis Susceptibility Share Common Amino Acid Polymorphisms and Epitope Binding Repertoires.
de Vrij N; Meysman P; Gielis S; Adriaensen W; Laukens K; Cuypers B
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33803005
[TBL] [Abstract][Full Text] [Related]
14. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
Kashyap M; Jaiswal V; Farooq U
Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
Fernandez CA; Smith C; Yang W; Daté M; Bashford D; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Turner V; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
Blood; 2014 Aug; 124(8):1266-76. PubMed ID: 24970932
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V
Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654
[TBL] [Abstract][Full Text] [Related]
17. Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.
Chow IT; James EA; Gates TJ; Tan V; Moustakas AK; Papadopoulos GK; Kwok WW
J Immunol; 2013 May; 190(9):4516-24. PubMed ID: 23543758
[TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-DRB1*09:01-restricted Mycobacterium tuberculosis CD4
Liu SD; Zhang SM; Wang H; He JC; Yang XF; Du XL; Ma L
FEBS Lett; 2016 Dec; 590(24):4541-4549. PubMed ID: 27861807
[TBL] [Abstract][Full Text] [Related]
19. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
[TBL] [Abstract][Full Text] [Related]
20. MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.
Cui Z; Xie LJ; Chen FJ; Pei ZY; Zhang LJ; Qu Z; Huang J; Gu QH; Zhang YM; Wang X; Wang F; Meng LQ; Liu G; Zhou XJ; Zhu L; Lv JC; Liu F; Zhang H; Liao YH; Lai LH; Ronco P; Zhao MH
J Am Soc Nephrol; 2017 May; 28(5):1651-1664. PubMed ID: 27852637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
